Cargando…

Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy

The mucosal immune system, via a dynamic immune network, serves as the first line of defense against exogenous antigens. Mucosal immune system dysregulation is closely associated with the pathogenesis of immunoglobulin A nephropathy (IgAN), as illustrated by IgAN having the clinical feature of gross...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kano, Toshiki, Suzuki, Hitoshi, Makita, Yuko, Nihei, Yoshihito, Fukao, Yusuke, Nakayama, Maiko, Lee, Mingfeng, Kato, Rina, Aoki, Ryosuke, Yamada, Koshi, Muto, Masahiro, Suzuki, Yusuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775168/ https://www.ncbi.nlm.nih.gov/pubmed/36551783 http://dx.doi.org/10.3390/biomedicines10123027

Ejemplares similares

Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy
por: Lee, Mingfeng, et al.
Publicado: (2020)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Clinical Significance of the Intensity of Glomerular Galactose-Deficient IgA1 Deposition in IgA Nephropathy
por: Nakayama, Maiko, et al.
Publicado: (2022)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Identification of IgA autoantibodies targeting mesangial cells redefines the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Ethnicity and IgA nephropathy: worldwide differences in epidemiology, timing of diagnosis, clinical manifestations, management and prognosis
por: Lee, Mingfeng, et al.
Publicado: (2023)

IgA Nephropathy with Gross Hematuria Following COVID-19 mRNA Vaccination
por: Nihei, Yoshihito, et al.
Publicado: (2022)

cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy
por: Misaki, Taro, et al.
Publicado: (2023)

Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy
por: Yasutake, Junichi, et al.
Publicado: (2015)

Dietary Zinc Is a Key Environmental Modifier in the Progression of IgA Nephropathy
por: Maiguma, Masayuki, et al.
Publicado: (2014)

Glomerular deposition of galactose-deficient IgA1-containing immune complexes via glomerular endothelial cell injuries
por: Makita, Yuko, et al.
Publicado: (2022)

Different Pathological Roles of Toll-Like Receptor 9 on Mucosal B Cells and Dendritic Cells in Murine IgA Nephropathy
por: Kajiyama, Tadahiro, et al.
Publicado: (2011)

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
por: Placzek, William J., et al.
Publicado: (2018)

Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy
por: Nakata, Junichiro, et al.
Publicado: (2014)

Utility of remission criteria for the renal prognosis of IgA nephropathy
por: Matsuzaki, Keiichi, et al.
Publicado: (2021)

Pathological Role of Tonsillar B Cells in IgA Nephropathy
por: Suzuki, Yusuke, et al.
Publicado: (2011)

A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases
por: Yanagawa, Hiroyuki, et al.
Publicado: (2014)

Uncoupling of Glomerular IgA Deposition and Disease Progression in Alymphoplasia Mice with IgA Nephropathy
por: Aizawa, Masashi, et al.
Publicado: (2014)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

Continuous extracorporeal treatments in a dialysis patient with COVID-19
por: Nihei, Yoshihito, et al.
Publicado: (2020)

Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy
por: Yamada, Koshi, et al.
Publicado: (2017)

Exacerbation of IgA nephropathy in a patient receiving dupilumab
por: Yamamoto, Masako, et al.
Publicado: (2022)

Pathogenic Role of a Proliferation-Inducing Ligand (APRIL) in Murine IgA Nephropathy
por: Kim, Yang Gyun, et al.
Publicado: (2015)

Successful Management of Critical Acute Respiratory Distress Syndrome following COVID-19 through Extracorporeal Membrane Oxygenation in a Patient with Concurrent Nephrotic Syndrome Relapse
por: Muto, Masahiro, et al.
Publicado: (2023)

Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy
por: Satake, Kenji, et al.
Publicado: (2014)

Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis
por: Suzuki, Hitoshi
Publicado: (2018)

COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine
por: Fukao, Yusuke, et al.
Publicado: (2021)

TWEAK/Fn14 system and crescent formation in IgA nephropathy
por: Sasaki, Yohei, et al.
Publicado: (2015)

The mucosal immune system and IgA nephropathy
por: Gesualdo, Loreto, et al.
Publicado: (2021)

Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in Japan
por: Matsuzaki, Keiichi, et al.
Publicado: (2021)

Correction to: Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in Japan
por: Matsuzaki, Keiichi, et al.
Publicado: (2021)

Special Issue: New Insights into the Pathogenesis and Therapies of IgA Nephropathy
por: Suzuki, Hitoshi, et al.
Publicado: (2022)

Nationwide survey on current treatments for IgA nephropathy in Japan
por: Matsuzaki, Keiichi, et al.
Publicado: (2013)

Impact of Transferrin Saturation and Anemia on Radial Artery Calcification in Patients with End-Stage Kidney Disease
por: Kano, Toshiki, et al.
Publicado: (2022)

Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy
por: Maruyama, Shuntaro, et al.
Publicado: (2016)

Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1
por: Yamasaki, Kohei, et al.
Publicado: (2018)

Diagnosis and activity assessment of immunoglobulin A nephropathy: current perspectives on noninvasive testing with aberrantly glycosylated immunoglobulin A-related biomarkers
por: Suzuki, Yusuke, et al.
Publicado: (2014)

The Kinetics of Glomerular Deposition of Nephritogenic IgA
por: Yamaji, Kenji, et al.
Publicado: (2014)

Circulating TNF Receptors 1 and 2 Are Associated with the Severity of Renal Interstitial Fibrosis in IgA Nephropathy
por: Sonoda, Yuji, et al.
Publicado: (2015)

Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria
por: Barratt, Jonathan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b2e0fq8u728rtpmiflb6063sbl